Catalent Shares Volatile Over Last Few Mins Amid Report US Gov’t. Discussing Producing AstraZeneca’s COVID-19 Vaccine In A Co. Factory
https://www.nytimes.com/2021/06/02/us/politics/astrazeneca-covid-vaccine.html
Sorrento Therapeutics Looks Like It May Have Broken Out Of A Falling Wedge Pattern
Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares are trading higher Wednesday after the company announced it completed an acquisition of ACEA Therapeutics. The merger was completed June 1, and ACEA became a wholly owned subsidiary of Sorrento.
Myocarditis Cases Probably Linked to Pfizer COVID-19 Vaccine, Says Israel Health Ministry: Reuters
Israel’s Health Ministry has reportedly found the small number of heart inflammation cases, observed mainly in young men who…
US NIH Initiates Trial to Assess Mix-Match of COVID-19 Vaccine Booster Shots: CNBC
The National Institutes of Health (NIH) has started an early-stage clinical trial to assess what happens when a…
Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102
Protalix BioTherapeutics Inc (NYSE:PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX–102) for the…
Lilly’s Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial
Eli Lilly And Co (NYSE:LLY) has reported posthoc analyses data from the Phase 3 RA-BEAM study that showed Olumiant 4mg (baricitinib)…
Almost Half of Crohn’s Disease Patients Achieved Endoscopic Response After One Year of Maintenance Treatment with AbbVie’s Risankizumab
AbbVie Inc (NYSE: ABBV) has announced positive top-line results from the Phase 3 maintenance study, FORTIFY, showing Skyrizi (risankizumab) achieved the co-primary endpoints of endoscopic response and clinical remission at one year in Crohn's disease.
Watching Cruise Stocks As Traders Circulate June 1 CDC Info That It Approved 4 Test Cruises, Is Reviewing 6 More
https://www.royalcaribbeanblog.com/2021/06/02/cdc-has-approved-4-test-cruises-6-more-under-review
Venus Concept Shares Move Higher; Co Publishes Clinical Trial Titled ‘Mechanical Coring to Achieve Directional Skin Tightening’ To ClinicalTrials.Gov
https://clinicaltrials.gov/ct2/show/NCT04910945
Sorento Therapeutics Publishes Clinical Trial Titled ‘Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID Acute Respiratory Distress Syndrome’ To ClinicalTrials.Gov
https://clinicaltrials.gov/ct2/show/NCT04909879